Abstract
' The Top 10 Pharmaceutical Companies in India' examines the leading players in
the Indian pharmaceutical market comprising both India-based and multinational
companies. This report analyzes the Indian pharmaceutical industry in terms of
market size, key drivers and resistors, trends and competitive positioning in
the global market. It includes profiles of the top ten companies in the
industry and also involves a brief summary of top 11 to 20 players.
Table of Contents
Executive summary
- Industry overview
- Cipla
- Ranbaxy
- GSK (India)
- Piramal Healthcare
- Zydus Cadila
- Sun Pharma
- Lupin Laboratories (Lupin)
- Alkem
- Sanofi-Aventis (India)
- Mankind Pharma (Mankind)
Chapter 1 Introduction
- What is this report about?
- Methodology
Chapter 2 Industry overview
- Summary
- Introduction
- Market dynamics
- Indian pharmaceutical market: size and growth
- Key market drivers and resistors
- India' s adoption of product patent regime
- Evolution of biopharmaceuticals in India
- Competitive positioning of India in global pharmaceutical market
- Competitive landscape
- Competitive positioning of the top 10 companies
- Exposure to US generics market
- Comparative analysis of the top 10 companies
- Trends
- Increasing participation of innovator companies in Indian pharmaceutical
- space
- Pharmaceutical companies making inroads into rural India
- Shifting focus towards Japanese generics market
- Growing prevalence of lifestyle diseases
- Expanding alliances in biopharmaceuticals
Chapter 3 Cipla
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Expanding in international markets through alliances and partnerships
- Expanding capabilities
- Growing in the US generics market
- Acquisitions and divestments
- SWOT analysis
Chapter 4 Ranbaxy
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Rebuilding business in the US market
- Shifting focus towards complex products in the US
- Monetizing the FTF opportunities in the US
- Improving penetration in emerging markets
- Strengthening management involvement in Ranbaxy
- Acquisitions and divestments
- SWOT analysis
Chapter 5 GSK (India)
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Augmenting product portfolio in India
- Leveraging its parent company' s product portfolio
- In-licensing products
- Expanding rural presence and hospital sales
- Acquisitions and divestments
- SWOT analysis
Chapter 6 Piramal Healthcare
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Capitalize on contract manufacturing opportunities
- Growing business through alliances and partnerships
- Acquisitions and divestments
- SWOT analysis
Chapter 7 Zydus Cadila
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Alliances fostering growth in international generics markets
- Sustaining revenue growth in Indian formulation business
- Acquisitions and divestments
- SWOT analysis
Chapter 8 Sun Pharma
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Enhancing presence in the US market
- Focusing on niche segments in developing markets
- Plugging gaps in its business through investments
- Acquisitions and divestments
- SWOT analysis
Chapter 9 Lupin
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Expanding in European markets
- Foray into biosimilars market
- Sustaining growth in the US generics market
- Shifting focus to chronic and specialized products in India
- Acquisitions and divestments
- SWOT analysis
Chapter 10 Alkem
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Expanding presence in nutraceuticals business
- Expansion in international markets
- Acquisitions and divestments
- SWOT analysis
Chapter 11 Sanofi-Aventis (India)
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Leveraging parent company' s product portfolio
- Shifting focus to rural India
- Acquisitions and divestments
- SWOT analysis
Chapter 12 Mankind
- Summary
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Growth strategies
- Expanding in international markets
- Investing in pharmaceutical capabilities development
- Foray into fast growing segments
- Acquisitions and divestments
- SWOT analysis
Chapter 13 11 - 20 companies
- Abbott (India)
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Dr Reddy' s
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Wockhardt
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Aristo
- Company overview
- Marketed products
- Therapeutic focus
- Torrent Pharmaceuticals (Torrent)
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Pfizer (India)
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Intas
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Alembic
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- FDC
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
- Macleods Pharmaceuticals (Macleods)
- Company overview
- Marketed products
- Therapeutic focus
- Research and development
Chapter 14 Appendix
List of Figures
- Figure 2.1: Indian pharmaceutical market size ($m), 2009 - 14
- Figure 2.2: Key market drivers and resistors of Indian pharmaceutical
market
- Figure 2.3: Indian pharmaceutical market SWOT analysis
- Figure 2.4: Top 10 pharmaceutical companies in India market share, 2008
- Figure 2.5: Top 10 pharmaceutical companies in India growth, 2004 - 08
- Figure 2.6: Comparative analysis of the top Indian pharmaceutical companies
- Figure 2.7: Top 10 pharmaceutical companies in India lifestyle segment
market share (%), 2008
- Figure 3.8: Cipla therapeutic focus, 2007 - 08
- Figure 3.9: Cipla SWOT analysis
- Figure 4.10: Ranbaxy therapeutic focus, 2007 - 08
- Figure 4.11: Ranbaxy SWOT analysis
- Figure 5.12: GSK (India) therapeutic focus, 2007 - 08
- Figure 5.13: GSK (India) SWOT analysis
- Figure 6.14: Piramal Healthcare therapeutic focus, 2007 - 08
- Figure 6.15: Piramal Healthcare SWOT analysis
- Figure 7.16: Zydus Cadila therapeutic focus, 2007 - 08
- Figure 7.17: Zydus Cadila SWOT analysis
- Figure 8.18: Sun Pharma therapeutic focus, 2007 - 08
- Figure 8.19: Sun Pharma SWOT analysis
- Figure 9.20: Lupin therapeutic focus, 2007 - 08
- Figure 9.21: Lupin SWOT analysis
- Figure 10.22: Alkem therapeutic focus, 2007 - 08
- Figure 10.23: Alkem SWOT analysis
- Figure 11.24: Sanofi-Aventis (India) therapeutic focus, 2007 - 08
- Figure 11.25: Sanofi-Aventis (India) SWOT analysis
- Figure 12.26: Mankind therapeutic focus, 2007 - 08
- Figure 12.27: Mankind SWOT analysis
- Figure 13.28: Abbott (India) therapeutic focus, 2007 - 08
- Figure 13.29: Dr Reddy' s therapeutic focus, 2007 - 08
- Figure 13.30: Wockhardt therapeutic focus, 2007 - 08
- Figure 13.31: Aristo therapeutic focus, 2007 - 08
- Figure 13.32: Torrent therapeutic focus, 2007 - 08
- Figure 13.33: Pfizer (India) therapeutic focus, 2007 - 08
- Figure 13.34: Intas therapeutic focus, 2007 - 08
- Figure 13.35: Alembic therapeutic focus, 2007 - 08
- Figure 13.36: FDC therapeutic focus, 2007 - 08
- Figure 13.37: Macleods therapeutic focus, 2007 - 08
List of Tables
- Table 2.1: Indian pharmaceutical market size ($m), 2009 - 14
- Table 2.2: Novel product pipeline of select Indian biotechnology
companies, 2008
- Table 2.3: Major foreign acquisitions by Indian pharmaceutical companies,
2007 - 09
- Table 2.4: Top 10 pharmaceutical companies in India growth (%), 2004 - 08
- Table 2.5: Selected ANDA filings approved in the US, 2009
- Table 2.6: Deals and alliances in Japanese pharmaceutical market, 2007 - 09
- Table 2.7: Selected alliances in the Indian biopharmaceutical market, 2007
- 09
- Table 3.8: Cipla snapshot
- Table 3.9: Cipla top 10 marketed products sales ($m), 2007 - 08
- Table 3.10: Cipla new product launches, 2007 - 08
- Table 3.11: Approved ANDAs of Cipla in the US, 2007 - 09
- Table 4.12: Ranbaxy snapshot
- Table 4.13: Ranbaxy top 10 marketed products sales in India ($m), 2007 - 08
- Table 4.14: Selected Ranbaxy ANDAs with FTF status
- Table 4.15: Ranbaxy acquisitions, 2007 - 09
- Table 5.16: GSK (India) snapshot
- Table 5.17: GSK (India) top 10 marketed products sales ($m), 2007 - 08
- Table 5.18: GSK (India) product launches from parent portfolio, 2007 - 09
- Table 5.19: GSK (India) expected new launches in India, 2009 - 10.
- Table 6.20: Piramal Healthcare snapshot
- Table 6.21: Piramal Healthcare top 10 marketed products sales ($m), 2007 -
08
- Table 6.22: Piramal Healthcare new product launches, 2007 - 08
- Table 6.23: Select Piramal Healthcare' s alliances, 2007 - 09
- Table 6.24: Piramal Healthcare acquisitions, 2007 - 09
- Table 7.25: Zydus Cadila snapshot
- Table 7.26: Zydus Cadila top 10 marketed products sales ($m), 2007 - 08
- Table 7.27: Zydus Cadila R&D collaborations, 2007 - 09
- Table 7.28: Select Zydus Cadila' s alliances, 2005 - 09
- Table 7.29: Zydus Cadila acquisitions, 2007 - 09
- Table 8.30: Sun Pharma snapshot
- Table 8.31: Sun Pharma top 10 marketed products sales ($m), 2007 - 08
- Table 8.32: Sun Pharma new product launches, 2007 - 08
- Table 9.33: Lupin snapshot
- Table 9.34: Lupin top 10 marketed products sales ($m), 2007 - 08
- Table 9.35: Lupin acquisitions, 2007 - 09
- Table 10.36: Alkem snapshot
- Table 10.37: Alkem top 10 marketed products sales ($m), 2007 - 08
- Table 11.38: Sanofi-Aventis (India) snapshot
- Table 11.39: Sanofi-Aventis (India) top 10 marketed products sales ($m),
2007 - 08
- Table 11.40: Sanofi-Aventis (India) key brands launches from parent
portfolio
- Table 12.41: Mankind snapshot
- Table 12.42: Mankind top 10 marketed products sales ($m), 2007 - 08
- Table 13.43: Abbott (India) snapshot
- Table 13.44: Abbott (India) top 10 marketed products sales ($m), 2007 - 08
- Table 13.45: Dr Reddy' s snapshot
- Table 13.46: Dr Reddy' s top 10 marketed products sales ($m), 2007 - 08
- Table 13.47: Dr Reddy' s drug development pipeline, 2007 - 08
- Table 13.48: Wockhardt snapshot
- Table 13.49: Wockhardt top 10 marketed products sales ($m), 2007 - 08
- Table 13.50: Aristo snapshot
- Table 13.51: Aristo top 10 marketed products sales ($m), 2007 - 08
- Table 13.52: Torrent snapshot
- Table 13.53: Torrent top 10 marketed products sales ($m), 2007 - 08
- Table 13.54: Pfizer (India) snapshot
- Table 13.55: Pfizer (India) top 10 marketed products sales ($m), 2007 - 08
- Table 13.56: Intas snapshot
- Table 13.57: Intas top 10 marketed products sales ($m), 2007 - 08
- Table 13.58: Alembic snapshot
- Table 13.59: Alembic top 10 marketed products sales ($m), 2007 - 08
- Table 13.60: FDC snapshot
- Table 13.61: FDC top 10 marketed products sales ($m), 2007 - 08
- Table 13.62: Selected FDC new product launches, 2007 - 08
- Table 13.63: Macleods snapshot
- Table 13.64: Macleods top 10 marketed products sales($m), 2007 - 08
|
相關報告
|
